EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes

İffet Merve Uçar Baytaroğlu, Ata Baytaroğlu iD, Merve Uçar Toros iD, Hatice Daldal iD

Graefe's Archive for Clinical and Experimental Ophthalmology · 2024

DOI: 10.1007/s00417-024-06529-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2024. Verfasst von İffet Merve Uçar Baytaroğlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Uşak Training and Research Hospital, Uşak, Turkey. ucarmerve1988@hotmail.com. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Usak University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the impact of anti-TNF (biological) therapies on the incidence and progression of diabetic retinopathy. Materials and methods A cross-sectional analysis of 50 diabetic patients with rheumatic diseases (group 1) was performed. An age-, sex-, and HbA1c-matched control group (group 2) was formed from a pool of diabetic patients who underwent regular eye examinations. The presence or absence of diabetic retinopathy was also assessed. Comorbidities such as hypertension, coronary artery disease, and hyperlipidemia were also evaluated as possible confounding factors.

Results

Hundred eyes of 50 patients were evaluated in each group. Only three patients in group 1 had non-proliferative retinopathy. The median duration of rheumatic disease was 9 years, whereas that of diabetes was 11 years. The mean duration of anti-TNF therapy was 4 years. In the control group of diabetes-only patients, 13 patients developed some form of newly diagnosed diabetic retinopathy during the last five years. The calculated retinopathy occurrence between the groups was statistically significant ( p < 0.05). In this study, the incidence rate ratio for patients receiving anti-TNF treatment was calculated as 0.4 in the study.

Conclusion

TNF inhibitors, with their anti-inflammatory effects, positively impact diabetic complications by reducing the incidence of retinopathy. To our knowledge, this is the first study to evaluate retinopathy development after anti-TNF therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2Tumor Necrosis Factor-alphaHumansMaleFemaleIncidenceCross-Sectional StudiesMiddle AgedRheumatic DiseasesAgedGlycated HemoglobinAntirheumatic AgentsFollow-Up StudiesRetrospective Studies

Stichwörter der Autor:innen

Anti-TNFDiabetes complicationsRetinopathyRheumatic disease

Substanzen

Tumor Necrosis Factor-alphaGlycated HemoglobinAntirheumatic Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • Rheumatology Department, Uşak Training and Research Hospital, Uşak, Turkey. ucarmerve1988@hotmail.com.
  • Ophthalmology Department, Uşak Training and Research Hospital, Uşak, Turkey.
  • Endocrinology Department, Uşak Training and Research Hospital, Uşak, Turkey.

ORCID-Profile: Ata Baytaroğlu, Merve Uçar Toros, Hatice Daldal

Förderung

  • Usak University

Zitieren

APA

Baytaroğlu, İ. M. U., Baytaroğlu, A., Toros, M. U., & Daldal, H. (2024). Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-024-06529-3

Vancouver

Baytaroğlu İMU, Baytaroğlu A, Toros MU, Daldal H. Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. doi:10.1007/s00417-024-06529-3

BibTeX
@article{Baytarolu2024,
  author = {Baytaroğlu, İffet Merve Uçar and Baytaroğlu, Ata and Toros, Merve Uçar and Daldal, Hatice},
  title = {Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes},
  journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
  year = {2024},
  doi = {10.1007/s00417-024-06529-3}
}
Kostenlos starten →